• By Billy Chen
  • Posted December 13, 2017

Finding Answers to Neurological Disorders with Clinical Exome Sequencing

At Ambry, “Finding Answers” is at the core of what we do.  We know patients and clinicians depend on us to find answers that help them better understand diseases, and improve outcomes.   2017 has been a busy and productive year for Ambry.  In particular, using Ambry’s clinical exome test, ExomeNext, we have been successful in identifying …

  • By Billy Chen
  • Posted November 15, 2017

Precision Medicine for Epilepsy is Within our Reach

Precision medicine is an emerging healthcare model built on the idea that drugs designed to target precise genetic causes of diseases will be cheaper, safer and most importantly, more effective for patients with a mutation.   Although precision medicine applies to all therapeutic areas, the rapid progress in identifying new epilepsy genes represents …

  • By Taylor Leigh
  • Posted August 15, 2017

Ambry Advances Understanding of Human Disease Through Epilepsy Gene Research

  At Ambry, we believe working together is better, that sharing data is essential to finding answers faster. Our scientists embody these beliefs by collaborating with other talented researchers and physicians to understand human disease, most recently in epilepsy genetics. We are proud to have contributed to the clinical research reviewed …

  • By Jackie Connor
  • Posted November 23, 2016

'The Color Violet' Documentary to Premiere at American Epilepsy Society's Annual Meeting

  Ambry is proud to introduce “The Color Violet,” a documentary created in collaboration with the PCDH19 Alliance and UCSF Benioff Children’s Hospital. The film explores the life of a 9-year-old girl, Violet McManus, and her family’s collective journey with PCDH19-related epilepsy. The film also explores the latest available …